Athira Pharma Statistics

Total Valuation

Athira Pharma has a market cap or net worth of $95.82 million. The enterprise value is -$25.40 million.

Market Cap	95.82M
Enterprise Value	-25.40M

Important Dates

The last earnings date was Wednesday, May 15, 2024, after market close.

Earnings Date	May 15, 2024
Ex-Dividend Date	n/a

Share Statistics

Athira Pharma has 38.33 million shares outstanding. The number of shares has increased by 1.05% in one year.

Shares Outstanding	38.33M
Shares Change (YoY)	+1.05%
Shares Change (QoQ)	+0.58%
Owned by Insiders (%)	2.27%
Owned by Institutions (%)	62.46%
Float	26.92M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.90
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.03, with a Debt / Equity ratio of 0.01.

Current Ratio	5.03
Quick Ratio	n/a
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -80.60% and return on invested capital (ROIC) is -113.99%.

Return on Equity (ROE)	-80.60%
Return on Assets (ROA)	-67.70%
Return on Capital (ROIC)	-113.99%
Revenue Per Employee	n/a
Profits Per Employee	-$1.79M
Employee Count	65
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.70% in the last 52 weeks. The beta is 2.84, so Athira Pharma's price volatility has been higher than the market average.

Beta (1Y)	2.84
52-Week Price Change	-8.70%
50-Day Moving Average	2.35
200-Day Moving Average	2.40
Relative Strength Index (RSI)	58.23
Average Volume (30 Days)	339,014

Short Selling Information

The latest short interest is 1.05 million, so 2.74% of the outstanding shares have been sold short.

Short Interest	1.05M
Short Previous Month	1.04M
Short % of Shares Out	2.74%
Short % of Float	3.91%
Short Ratio (days to cover)	5.64

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-123.38M
Pretax Income	-116.19M
Net Income	-116.19M
EBITDA	-114.99M
EBIT	-116.19M
Earnings Per Share (EPS)	-$3.05

Full Income Statement

Balance Sheet

The company has $122.72 million in cash and $1.50 million in debt, giving a net cash position of $121.22 million or $3.16 per share.

Cash & Cash Equivalents	122.72M
Total Debt	1.50M
Net Cash	121.22M
Net Cash Per Share	$3.16
Equity / Book Value	106.74M
Book Value Per Share	2.79
Working Capital	103.04M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$100.36 million and capital expenditures -$68,000, giving a free cash flow of -$100.43 million.

Operating Cash Flow	-100.36M
Capital Expenditures	-68,000
Free Cash Flow	-100.43M
FCF Per Share	-$2.62

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Athira Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.05%
Shareholder Yield	-1.05%
Earnings Yield	-121.26%
FCF Yield	-104.82%

Analyst Forecast

The average price target for Athira Pharma is $19.00, which is 653.97% higher than the current price. The consensus rating is "Buy".

Price Target	$19.00
Price Target Difference	653.97%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2